Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Familial leukemia.

Kathleen F Benson1, Marshall Horwitz

  • 1Division of Medical Genetics, Department of Medicine, University of Washington School of Medicine, Box 357720, Seattle, WA 98195, USA.

Best Practice & Research. Clinical Haematology
|March 7, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the path: Advice to physician-scientists on choosing a clinical specialty.

eLife·2026
Same author

Differential Immune Activating, Anti-Inflammatory, and Regenerative Properties of the Aqueous, Ethanol, and Solid Fractions of a Medicinal Mushroom Blend.

Journal of inflammation research·2020
Same author

The mycelium of the Trametes versicolor (Turkey tail) mushroom and its fermented substrate each show potent and complementary immune activating properties in vitro.

BMC complementary and alternative medicine·2019
Same author

Rapid and selective mobilization of specific stem cell types after consumption of a polyphenol-rich extract from sea buckthorn berries (<i>Hippophae</i>) in healthy human subjects.

Clinical interventions in aging·2019
Same author

Case Report of an Adolescent Male With Unexplained Pancytopenia: <i>GATA2</i>-Associated Bone Marrow Failure and Genetic Testing.

Global pediatric health·2017
Same author

Water-soluble egg membrane enhances the immunoactivating properties of an <i>Aloe vera</i>-based extract of <i>Nerium oleander</i> leaves.

Clinical, cosmetic and investigational dermatology·2016

Identifying genes for rare familial leukemia offers insights into common cancer mechanisms. Discovering new genetic risk factors, including those for Down syndrome and telomere length, is crucial for understanding leukemia development.

Area of Science:

  • Oncology
  • Genetics
  • Cancer Research

Background:

  • Genetic factors play a significant role in leukemia risk.
  • Familial leukemia cases, though rare, provide crucial insights into carcinogenesis.
  • Most known genes for heritable leukemia risk are linked to bone marrow failure syndromes.

Purpose of the Study:

  • To identify novel genetic risk factors for leukemia.
  • To understand the genetic basis of leukemia in rare familial cases and Down syndrome.
  • To explore the mechanisms of carcinogenesis in both rare and common leukemia occurrences.

Main Methods:

  • Analysis of rare familial cancer cases to identify causative genes.
  • Investigation of genetic factors contributing to leukemia in Down syndrome.

Related Experiment Videos

  • Examination of gene variants associated with telomere length maintenance and anticipation in familial leukemia.

    • Main Results:

    • Identification of specific genes responsible for rare familial leukemia.
    • Understanding the unique clinical properties of leukemia in Down syndrome.
    • Confirmation of the association between telomere length genes and anticipation in familial leukemia.

    Conclusions:

    • Discovering genes for rare leukemias illuminates mechanisms in sporadic cancers.
    • Further research into genetic risk factors is essential for understanding and potentially treating leukemia.
    • Complex genetic and environmental interactions likely contribute to the majority of leukemia cases.